動物性胃食道逆流症の世界市場レポート 2025年

動物性胃食道逆流症市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.6％で27億6,000万米ドルに成長します。予測期間の成長は、ペットにおける消化器疾患の有病率の上昇、高度な診断・治療オプションに対する需要の高まり、ペットの健康に関する意識と教育の高まり、ペット保険の適用範囲と獣医サービスの拡大、動物用医薬品と治療法の進歩、可処分所得の上昇、ペットの健康に対する出費意欲に起因すると考えられます。予測期間における主な動向には、専門的で個別化された治療法、高度な診断ツールや技術の採用、獣医療行為とサービス、予防医療と食事管理、獣医療専門家と飼い主の連携などがあります。

ペットの人間化の進展が動物性胃食道逆流症（GERD）市場の成長を牽引すると予想されます。この動向は、飼い主がペットを人間の家族のように扱い、人間のような感情やニーズをペットに与えるようになってきており、飼い主とペットとの感情的な結びつきが深まっていることが背景にあります。ペットが家族の一員となるにつれ、専門的ヘルスケア、プレミアム・ダイエット、人間の基準に沿ったウェルネス製品への需要が高まっています。胃食道逆流症（GERD）などの疾患も含め、ペットの健康への関心が高まるにつれて、獣医療、診断、治療、予防対策への需要が高まる。例えば、2024年4月、米国ペット用品協会（American Pet Products Association）は、2023-2024年に米国でペットを飼っている世帯は8,690万世帯に達し、2022年の62％から66％に増加したと報告しました。このように、ペットの人間化が動物用GERD市場の成長を後押ししています。

動物用GERD市場の企業は、ペットの胃腸の健康をサポートし、GERD症状を管理するための特殊な食事の開発に注力しています。これらの胃腸サポート食は、胃腸障害の症状を緩和するように設計されたオーダーメイドのペットフードで、消化しやすい原材料、バランスの取れた栄養素、最適な消化器系の健康のための繊維質やプロバイオティクスの添加が特徴です。例えば、2024年4月、マース・インコーポレーテッドの子会社であるロイヤルカナンUSAは、ペットの消化器系の健康増進を目的とした5種類の新しいフードで、動物用胃腸（GI）シリーズを拡大しました。研究者や獣医師の意見を取り入れて開発されたこれらの食事は、食物に反応する過敏症や脂肪制限の必要性など、犬と猫両方の消化器系の問題に対応しています。新しい製品としては、消化管用低脂肪、犬用加水分解たん白、猫用加水分解たん白があり、いずれも長期的な胃腸の健康をサポートする消化性の高い原材料で作られています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界動物性胃食道逆流症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の動物性胃食道逆流症市場：成長率分析
• 世界の動物性胃食道逆流症市場の実績：規模と成長, 2019-2024
• 世界の動物性胃食道逆流症市場の予測：規模と成長, 2024-2029, 2034F
• 世界動物性胃食道逆流症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の動物性胃食道逆流症市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療
• 診断
• 世界の動物性胃食道逆流症市場モード別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 市販薬（OTC）
• 処方箋
• 世界の動物性胃食道逆流症市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 注射剤
• 世界の動物性胃食道逆流症市場：動物別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンパニオンアニマル
• 家畜
• 世界の動物性胃食道逆流症市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院とクリニック
• 小売薬局
• eコマース
• 世界の動物性胃食道逆流症市場、治療の細分化、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 外科的介入
• 食生活の変更
• 栄養補助食品
• 制酸剤
• 世界の動物性胃食道逆流症市場、診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 内視鏡検査
• 食道pHモニタリング
• マノメトリー
• 超音波
• 放射線学的研究
• 生検技術

第7章 地域別・国別分析

• 世界の動物性胃食道逆流症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の動物性胃食道逆流症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 動物性胃食道逆流症市場：競合情勢
• 動物性胃食道逆流症市場：企業プロファイル
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • VCA Animal Hospitals Overview, Products and Services, Strategy and Financial Analysis
  • Petco Health and Wellness Company Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck Animal Health Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Elanco Animal Health Incorporated
• Hill's Pet Nutrition Inc.
• IDEXX Laboratories Inc.
• Ceva Sante Animale
• Virbac S.A.
• Phibro Animal Health Corporation
• Dechra Pharmaceuticals PLC
• Blue Buffalo Company Ltd.
• Vetoquinol S.A.
• Antech Diagnostics
• Heska Corporation
• WellPet LLC
• McNeil Consumer Pharmaceuticals Co.
• Wag Labs Inc.
• VetPartners Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 動物性胃食道逆流症市場2029：新たな機会を提供する国
• 動物性胃食道逆流症市場2029：新たな機会を提供するセグメント
• 動物性胃食道逆流症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Animal gastroesophageal reflux disease (GERD) occurs when stomach acid or bile flows back into the esophagus, leading to irritation and inflammation. This condition can cause symptoms such as vomiting, regurgitation, weight loss, and discomfort during eating. Diagnosing and treating GERD in animals aims to relieve discomfort, enhance quality of life, and prevent complications such as esophagitis, ulcers, or strictures.

The main product types for managing animal GERD include treatment and diagnostic options. Treatment involves products designed to manage and alleviate GERD symptoms in animals, such as antacids, proton pump inhibitors, and other medications that reduce stomach acid and support digestive health. These treatments are available in over-the-counter (OTC) and prescription forms, with administration routes including oral and injectable. GERD treatments are used for both companion animals and livestock. Distribution channels for these products include veterinary hospitals and clinics, retail pharmacies, and e-commerce platforms.

The animal gastroesophageal reflux disease market research report is one of a series of new reports from the business research company that provides animal gastroesophageal reflux disease market statistics, including animal gastroesophageal reflux disease industry global market size, regional shares, competitors with an animal gastroesophageal reflux disease market share, detailed animal gastroesophageal reflux disease market segments, market trends and opportunities, and any further data you may need to thrive in the animal gastroesophageal reflux disease industry. This animal gastroesophageal reflux disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The animal gastroesophageal reflux disease market size has grown strongly in recent years. It will grow from $1.82 billion in 2024 to $1.98 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to an increase in pet obesity rates, advances in veterinary diagnostic technologies, growing awareness of gastrointestinal disorders in pets, improved veterinary care and treatment options, increased pet ownership and expenditure on pet health, and the and the development of specialized veterinary pharmaceuticals and diets.

The animal gastroesophageal reflux disease market size is expected to see strong growth in the next few years. It will grow to $2.76 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising prevalence of gastrointestinal disorders in pets, growing demand for advanced diagnostic and treatment options, increasing awareness and education about pet health, expanding pet insurance coverage and veterinary services, advancements in veterinary pharmaceuticals and treatments, rising disposable incomes, and willingness to spend on pet health. Major trends in the forecast period include specialized and personalized treatment options, adoption of advanced diagnostic tools and technologies, veterinary practices and services, preventive care and dietary management, and collaboration between veterinary professionals and pet owners.

The rising humanization of pets is anticipated to drive the growth of the animal gastroesophageal reflux disease (GERD) market. This trend, where pet owners increasingly treat their pets such as human family members and ascribe human-like emotions and needs to them, is fueled by deeper emotional bonds between owners and their pets. As pets are integrated more into family life, there is a heightened demand for specialized healthcare, premium diets, and wellness products that align with human standards. This increased focus on pet health, including conditions such as gastroesophageal reflux disease (GERD), leads to greater demand for veterinary care, diagnostics, treatments, and preventive measures. For example, in April 2024, the American Pet Products Association reported that 86.9 million households in the US had pets in 2023-2024, representing 66% of households, up from 62% in 2022. Thus, the humanization of pets is boosting the growth of the animal GERD market.

Companies in the animal GERD market are focusing on developing specialized diets to support gastrointestinal health and manage GERD symptoms in pets. These gastrointestinal support diets are tailored pet foods designed to alleviate symptoms of gastrointestinal disorders, featuring easily digestible ingredients, balanced nutrients, and added fibers or probiotics for optimal digestive health. For instance, in April 2024, Royal Canin USA, a subsidiary of Mars Incorporated, expanded its veterinary gastrointestinal (GI) range with five new diets aimed at enhancing pet digestive health. These diets, developed with input from researchers and veterinarians, address GI issues in both dogs and cats, including food-responsive sensitivities and fat-restricted needs. New offerings include gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline, all crafted with highly digestible ingredients to support long-term gastrointestinal health.

In August 2022, CHW Acquisition Corporation (CHW), a US-based investment firm, merged with Wag Labs Inc. for $350 million. This merger allows Wag to leverage its strengthened financial position to expand its subscription services, enhance its technology platform, and broaden its pet care offerings. Wag Labs Inc. provides guidance and solutions for treating animal GERD.

Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Sante Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc. , VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC

North America was the largest region in the animal gastroesophageal reflux disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the animal gastroesophageal reflux disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The animal gastroesophageal reflux disease market consists of revenues earned by entities by providing services such as specialized veterinary care, prescription medications, diagnostic testing and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The animal gastroesophageal reflux disease market also includes sales of gastrointestinal support diets, medications and hydrolyzed protein diets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Animal Gastroesophageal Reflux Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on animal gastroesophageal reflux disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for animal gastroesophageal reflux disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The animal gastroesophageal reflux disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Treatment; Diagnostics
• 2) By Mode: Over-The-Counter (OTC); Prescription
• 3) By Route Of Administration: Oral; Injectable
• 4) By Animal: Companion Animals; Livestock Animal
• 5) By Distribution Channel: Veterinary Hospitals And Clinics; Retail Pharmacies; E-Commerce
• Subsegments:
• 1) By Treatment: Medications; Surgical Interventions; Dietary Modifications; Nutritional Supplements; Antacids
• 2) By Diagnostics: Endoscopy; Esophageal pH Monitoring; Manometry; Ultrasound; Radiographic Studies; Biopsy Techniques
• Companies Mentioned: Zoetis Inc.; VCA Animal Hospitals; Petco Health and Wellness Company Inc.; Merck Animal Health; Boehringer Ingelheim Animal Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Animal Gastroesophageal Reflux Disease Market Characteristics

3. Animal Gastroesophageal Reflux Disease Market Trends And Strategies

4. Animal Gastroesophageal Reflux Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Animal Gastroesophageal Reflux Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Animal Gastroesophageal Reflux Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Animal Gastroesophageal Reflux Disease Market Growth Rate Analysis
• 5.4. Global Animal Gastroesophageal Reflux Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Animal Gastroesophageal Reflux Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Animal Gastroesophageal Reflux Disease Total Addressable Market (TAM)

6. Animal Gastroesophageal Reflux Disease Market Segmentation

• 6.1. Global Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Treatment
• Diagnostics
• 6.2. Global Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Over-The-Counter (OTC)
• Prescription
• 6.3. Global Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• 6.4. Global Animal Gastroesophageal Reflux Disease Market, Segmentation By Animal, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Companion Animals
• Livestock Animal
• 6.5. Global Animal Gastroesophageal Reflux Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals And Clinics
• Retail Pharmacies
• E-commerce
• 6.6. Global Animal Gastroesophageal Reflux Disease Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Surgical Interventions
• Dietary Modifications
• Nutritional Supplements
• Antacids
• 6.7. Global Animal Gastroesophageal Reflux Disease Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endoscopy
• Esophageal pH Monitoring
• Manometry
• Ultrasound
• Radiographic Studies
• Biopsy Techniques

7. Animal Gastroesophageal Reflux Disease Market Regional And Country Analysis

• 7.1. Global Animal Gastroesophageal Reflux Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Animal Gastroesophageal Reflux Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Animal Gastroesophageal Reflux Disease Market

• 8.1. Asia-Pacific Animal Gastroesophageal Reflux Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Animal Gastroesophageal Reflux Disease Market

• 9.1. China Animal Gastroesophageal Reflux Disease Market Overview
• 9.2. China Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Animal Gastroesophageal Reflux Disease Market

• 10.1. India Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Animal Gastroesophageal Reflux Disease Market

• 11.1. Japan Animal Gastroesophageal Reflux Disease Market Overview
• 11.2. Japan Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Animal Gastroesophageal Reflux Disease Market

• 12.1. Australia Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Animal Gastroesophageal Reflux Disease Market

• 13.1. Indonesia Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Animal Gastroesophageal Reflux Disease Market

• 14.1. South Korea Animal Gastroesophageal Reflux Disease Market Overview
• 14.2. South Korea Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Animal Gastroesophageal Reflux Disease Market

• 15.1. Western Europe Animal Gastroesophageal Reflux Disease Market Overview
• 15.2. Western Europe Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Animal Gastroesophageal Reflux Disease Market

• 16.1. UK Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Animal Gastroesophageal Reflux Disease Market

• 17.1. Germany Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Animal Gastroesophageal Reflux Disease Market

• 18.1. France Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Animal Gastroesophageal Reflux Disease Market

• 19.1. Italy Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Animal Gastroesophageal Reflux Disease Market

• 20.1. Spain Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Animal Gastroesophageal Reflux Disease Market

• 21.1. Eastern Europe Animal Gastroesophageal Reflux Disease Market Overview
• 21.2. Eastern Europe Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Animal Gastroesophageal Reflux Disease Market

• 22.1. Russia Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Animal Gastroesophageal Reflux Disease Market

• 23.1. North America Animal Gastroesophageal Reflux Disease Market Overview
• 23.2. North America Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Animal Gastroesophageal Reflux Disease Market

• 24.1. USA Animal Gastroesophageal Reflux Disease Market Overview
• 24.2. USA Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Animal Gastroesophageal Reflux Disease Market

• 25.1. Canada Animal Gastroesophageal Reflux Disease Market Overview
• 25.2. Canada Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Animal Gastroesophageal Reflux Disease Market

• 26.1. South America Animal Gastroesophageal Reflux Disease Market Overview
• 26.2. South America Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Animal Gastroesophageal Reflux Disease Market

• 27.1. Brazil Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Animal Gastroesophageal Reflux Disease Market

• 28.1. Middle East Animal Gastroesophageal Reflux Disease Market Overview
• 28.2. Middle East Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Animal Gastroesophageal Reflux Disease Market

• 29.1. Africa Animal Gastroesophageal Reflux Disease Market Overview
• 29.2. Africa Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Animal Gastroesophageal Reflux Disease Market Competitive Landscape And Company Profiles

• 30.1. Animal Gastroesophageal Reflux Disease Market Competitive Landscape
• 30.2. Animal Gastroesophageal Reflux Disease Market Company Profiles
  • 30.2.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. VCA Animal Hospitals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Petco Health and Wellness Company Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck Animal Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

31. Animal Gastroesophageal Reflux Disease Market Other Major And Innovative Companies

• 31.1. Elanco Animal Health Incorporated
• 31.2. Hill's Pet Nutrition Inc.
• 31.3. IDEXX Laboratories Inc.
• 31.4. Ceva Sante Animale
• 31.5. Virbac S.A.
• 31.6. Phibro Animal Health Corporation
• 31.7. Dechra Pharmaceuticals PLC
• 31.8. Blue Buffalo Company Ltd.
• 31.9. Vetoquinol S.A.
• 31.10. Antech Diagnostics
• 31.11. Heska Corporation
• 31.12. WellPet LLC
• 31.13. McNeil Consumer Pharmaceuticals Co.
• 31.14. Wag Labs Inc.
• 31.15. VetPartners Limited

32. Global Animal Gastroesophageal Reflux Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Animal Gastroesophageal Reflux Disease Market

34. Recent Developments In The Animal Gastroesophageal Reflux Disease Market

35. Animal Gastroesophageal Reflux Disease Market High Potential Countries, Segments and Strategies

• 35.1 Animal Gastroesophageal Reflux Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Animal Gastroesophageal Reflux Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Animal Gastroesophageal Reflux Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33394_Animal_Gastroesophageal_Reflux_Disease_GMR_2025